Loss of PTEN leads to constitutive activation of the phosphatidylinositol 3-kinases (PI3K)-AKT-mTOR signaling pathway so as to augment expression of metabolic genes regulated by SREBP1c and PPARγ in cancer proliferative cells [14,15,16]. The gene discussed is AKT1; the disease is cancer.